240 related articles for article (PubMed ID: 37020053)
1. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development.
Pires SF; de Barros JS; da Costa SS; de Oliveira Scliar M; Van Helvoort Lengert A; Boldrini É; da Silva SRM; Tasic L; Vidal DO; Krepischi ACV; Maschietto M
Mol Genet Genomics; 2023 May; 298(3):721-733. PubMed ID: 37020053
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Vaidya H; Rumph C; Katula KS
PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
[TBL] [Abstract][Full Text] [Related]
3. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
5. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation determines nucleosome occupancy in the 5'-CpG islands of tumor suppressor genes.
Portela A; Liz J; Nogales V; Setién F; Villanueva A; Esteller M
Oncogene; 2013 Nov; 32(47):5421-8. PubMed ID: 23686312
[TBL] [Abstract][Full Text] [Related]
7. Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome.
Drini M; Wong NC; Scott HS; Craig JM; Dobrovic A; Hewitt CA; Dow C; Young JP; Jenkins MA; Saffery R; Macrae FA
PLoS One; 2011 Feb; 6(2):e16831. PubMed ID: 21347319
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
Rajendran G; Shanmuganandam K; Bendre A; Muzumdar D; Goel A; Shiras A
J Neurooncol; 2011 Sep; 104(2):483-94. PubMed ID: 21229291
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
12. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
13. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.
Ghoshal K; Motiwala T; Claus R; Yan P; Kutay H; Datta J; Majumder S; Bai S; Majumder A; Huang T; Plass C; Jacob ST
PLoS One; 2010 Apr; 5(4):e10338. PubMed ID: 20454457
[TBL] [Abstract][Full Text] [Related]
14. PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation.
de la Rica L; Rodríguez-Ubreva J; García M; Islam AB; Urquiza JM; Hernando H; Christensen J; Helin K; Gómez-Vaquero C; Ballestar E
Genome Biol; 2013; 14(9):R99. PubMed ID: 24028770
[TBL] [Abstract][Full Text] [Related]
15. Promoter CpG island hypermethylation during breast cancer progression.
Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
[TBL] [Abstract][Full Text] [Related]
16. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.
Opavsky R; Wang SH; Trikha P; Raval A; Huang Y; Wu YZ; Rodriguez B; Keller B; Liyanarachchi S; Wei G; Davuluri RV; Weinstein M; Felsher D; Ostrowski M; Leone G; Plass C
PLoS Genet; 2007 Sep; 3(9):1757-69. PubMed ID: 17907813
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
[TBL] [Abstract][Full Text] [Related]
18. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
19. Aerobic exercise training resets the human skeletal muscle methylome 10 years after breast cancer treatment and survival.
Gorski PP; Raastad T; Ullrich M; Turner DC; Hallén J; Savari SI; Nilsen TS; Sharples AP
FASEB J; 2023 Jan; 37(1):e22720. PubMed ID: 36542473
[TBL] [Abstract][Full Text] [Related]
20. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]